ASO Visual Abstract: Association of Adjuvant Immunotherapy with Improved Survival for Stage II–III Esophageal Cancer: Four-Year National Perspective

Annals of Surgical Oncology 2026

View at publisher

Authors: Sara Sakowitz, Syed Shahyan Bakhtiyar, Yas Sanaiha, Peyman Benharash, Jane Yanagawa

DOI: 10.1245/s10434-026-19392-9

Cited by: 0

Fields of Study & Subjects

Esophageal Cancer Research and Treatment Gastric Cancer Management and Outcomes Cancer Immunotherapy and Biomarkers